These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16760725)

  • 1. Formal heparin anticoagulation protocol improves safety of charcoal-based liver-assist treatments.
    Hillebrand DJ; Hill KB; Hu KQ; Strutt M; Wilson B; Cottrell A; Teichman S; Hay K; Bull B
    ASAIO J; 2006; 52(3):334-42. PubMed ID: 16760725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charcoal-based hemodiabsorption liver support for episodic type C hepatic encephalopathy.
    Hill K; Hu KQ; Cottrell A; Teichman S; Hillebrand DJ
    Am J Gastroenterol; 2003 Dec; 98(12):2763-70. PubMed ID: 14687830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is 300 Seconds ACT Safe and Efficient during MiECC Procedures?
    Bauer A; Hausmann H; Schaarschmidt J; Szlapka M; Scharpenberg M; Eberle T; Hasenkam JM
    Thorac Cardiovasc Surg; 2019 Apr; 67(3):191-202. PubMed ID: 29290078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifactor Xa Activity for the Management of Anticoagulation during Cardiac Surgery.
    Reyher C; Würfel C; Lindhoff-Last E; Meybohm P; Zacharowski K; Moritz A; Schindewolf M; Weber CF
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):494-500. PubMed ID: 26757210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy.
    Nagarik AP; Soni SS; Adikey GK; Raman A
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):478-83. PubMed ID: 20427872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated clotting time during cardiopulmonary bypass: is repetition necessary during open heart surgery?
    Neema PK; Sinha PK; Rathod RC
    Asian Cardiovasc Thorac Ann; 2004 Mar; 12(1):47-52. PubMed ID: 14977742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation management during multivessel coronary artery bypass grafting: a randomized trial comparing individualized heparin management and conventional hemostasis management.
    Hoenicka M; Rupp P; Müller-Eising K; Deininger S; Kunert A; Liebold A; Gorki H
    J Thromb Haemost; 2015 Jul; 13(7):1196-206. PubMed ID: 25954849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin dose for accurate anticoagulation in cardiac surgery.
    Doty DB; Knott HW; Hoyt JL; Koepke JA
    J Cardiovasc Surg (Torino); 1979; 20(6):597-604. PubMed ID: 511928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival.
    Baird CW; Zurakowski D; Robinson B; Gandhi S; Burdis-Koch L; Tamblyn J; Munoz R; Fortich K; Pigula FA
    Ann Thorac Surg; 2007 Mar; 83(3):912-9; discussion 919-20. PubMed ID: 17307433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How much heparin do we really need to go on pump? A rethink of current practices.
    Shuhaibar MN; Hargrove M; Millat MH; O'Donnell A; Aherne T
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):947-50. PubMed ID: 15519187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More Effective Anticoagulation During Non-Cardiac Arterial Procedures Using Activated Clotting Time Guided Heparin Administration.
    Doganer O; Wiersema AM; Pierie M; Blankensteijn JD; Yeung KK; Jongkind V
    Ann Vasc Surg; 2021 Oct; 76():378-388. PubMed ID: 33951528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation with fondaparinux for hemodiafiltration in patients with heparin-induced thrombocytopenia: dose-finding study and safety evaluation.
    Mahieu E; Claes K; Jacquemin M; Evenepoel P; Op De Beek K; Bogaert AM; Kuypers D; Verhamme P; Meijers B
    Artif Organs; 2013 May; 37(5):482-7. PubMed ID: 23461610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
    Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
    Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Control of temporary anticoagulation in extracorporeal circulation using activated coagulation time].
    Kessler G; Grünes G
    Anaesthesist; 1984 Dec; 33(12):588-91. PubMed ID: 6528961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients.
    Atallah S; Liebl M; Fitousis K; Bostan F; Masud F
    Perfusion; 2014 Sep; 29(5):456-61. PubMed ID: 24570077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of heparin on coagulation index during the therapy of molecular adsorbent recirculating system in patients with liver failure].
    Yuan S; Zhou Y; Tan D; Li D; Zhou T; Xie Q; Fan J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):830-5. PubMed ID: 21946197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.